Muscle fibre type changes in hypothyroid myopathy.

Area of Science:

• Endocrinology
• Neurology
• Muscle Physiology

Background:

• Hypothyroid myopathy is a neuromuscular disorder associated with hypothyroidism.
• Muscle fiber alterations, particularly in type II fibers, are characteristic of this condition.

Purpose of the Study:

• To investigate changes in muscle fiber type composition during L-thyroxine treatment for hypothyroid myopathy.
• To correlate these changes with clinical and biochemical markers of the disease and assess long-term effects.

Main Methods:

• Serial percutaneous needle biopsies of the vastus lateralis muscle were performed.
• Muscle samples were analyzed for fiber type distribution before and during L-thyroxine therapy.

Main Results:

• A significant atrophy and loss of type II muscle fibers were observed, correlating with myopathy severity.
• L-thyroxine treatment effectively corrected type II fiber atrophy.
• However, type II fiber loss persisted in severely affected patients even after two years of treatment.

Conclusions:

• L-thyroxine treatment can reverse type II fiber atrophy in hypothyroid myopathy.
• Persistent type II fiber loss in severe cases suggests potential long-term muscle damage and impacts prognosis.
• Further research into the pathogenesis and long-term implications of type II fiber loss is warranted.